BIEL + VLMS + Viant: Smart Pain Relief Alliance with Exponential ROI Potential
The Perfect Replacement for KT Tape
Vision: Pain Relief That Powers Prosperity
Viant Medical and VLMS Healthcare aren’t just operational titans—they’re equity-aligned partners powering BIEL’s transition from product innovator to wealth-generation platform. Together, they form a distribution and manufacturing ecosystem poised to transform ActiPatch® from a wellness tool into an investment-grade asset.
BIEL’s FDA-cleared PEMF devices—ActiPatch®, RecoveryRx®, and RecoveryRx Vet®—deliver non-invasive pain relief backed by real performance and exponential ROI potential. It’s strategic execution via open-market equity, global scalability, and retail virality.
Viant Medical: Precision Manufacturing Powerhouse
Scales ActiPatch® with global logistics and high-volume production
Ensures FDA compliance, hospital-grade quality, and technical fulfillment
Delivers neuromodulation capabilities that align with future VNS evolution
VLMS Healthcare: Monetization & AI-Powered Distribution
Converts distribution into equity via PPS-driven partnerships
Provides backend billing, coaching, and digital infrastructure
Activates retail & influencer ecosystems with no bureaucracy or delay
Why They're “Better Than KT Tape”
Viant scales production for institutional access
VLMS accelerates market velocity and monetization
No regulatory drag—FDA clearance already secured
Best-case scenario: they collaborate, replacing KT Tape with a smarter, more scalable solution
Open-Market Equity Mechanics
Viant and VLMS acquire equity stakes in BIEL on the open market, capitalizing on the low PPS. That means:
No dilution, no cap table drama
Strategic execution directly drives ROI
Performance becomes profit—automatically
Equity alignment replaces complex M&A
Milestones to Watch
$0.0004–$0.0005: Technical breakout zone triggered by strategic partnerships
$0.003: Viral press momentum = 3,000% ROI
$0.01: Quarterly catalyst ($400K revenue) = copper-grade breakout
$0.04: Profit traction ($10M) = 40,000% Bitcoin-level surge
$0.10–$1.00: Full market momentum ($25M profit) = 100,000% return
Smart Tech + Lean Economics
AI app adapts therapy to user patterns
Tailors relief based on lifestyle, weather, and activity data
$35/month per device = Netflix-level affordability, no FDA bottlenecks
High-margin, low-overhead infrastructure allows scale across human & veterinary markets
Veterinary Opportunity
RecoveryRx Vet® outperforms Assisi Loop ($329) with 20x battery life
Premium e-commerce bundling opens a goldmine in pet wellness
Retail-ready, influencer-friendly, and margin-rich
Tax-Efficient Profitability
$40M tax-loss carryforward = early profits are tax-free
Viral press at $0.003 can trigger GameStop-style surge
Share buybacks post loan payoff drive valuation acceleration ($1/share?)
Final Word: Execute. Accumulate. Prosper.
Viant builds. VLMS bills. BIEL heals. Shareholders win.
This is Smart Pain Relief Alliance—where scalable pain therapy meets frictionless equity participation. No contracts. No barriers. Just the pure upside of execution-fueled prosperity.
The Perfect Replacement for KT Tape
Vision: Pain Relief That Powers Prosperity
Viant Medical and VLMS Healthcare aren’t just operational titans—they’re equity-aligned partners powering BIEL’s transition from product innovator to wealth-generation platform. Together, they form a distribution and manufacturing ecosystem poised to transform ActiPatch® from a wellness tool into an investment-grade asset.
BIEL’s FDA-cleared PEMF devices—ActiPatch®, RecoveryRx®, and RecoveryRx Vet®—deliver non-invasive pain relief backed by real performance and exponential ROI potential. It’s strategic execution via open-market equity, global scalability, and retail virality.
Viant Medical: Precision Manufacturing Powerhouse
Scales ActiPatch® with global logistics and high-volume production
Ensures FDA compliance, hospital-grade quality, and technical fulfillment
Delivers neuromodulation capabilities that align with future VNS evolution
VLMS Healthcare: Monetization & AI-Powered Distribution
Converts distribution into equity via PPS-driven partnerships
Provides backend billing, coaching, and digital infrastructure
Activates retail & influencer ecosystems with no bureaucracy or delay
Why They're “Better Than KT Tape”
Viant scales production for institutional access
VLMS accelerates market velocity and monetization
No regulatory drag—FDA clearance already secured
Best-case scenario: they collaborate, replacing KT Tape with a smarter, more scalable solution
Open-Market Equity Mechanics
Viant and VLMS acquire equity stakes in BIEL on the open market, capitalizing on the low PPS. That means:
No dilution, no cap table drama
Strategic execution directly drives ROI
Performance becomes profit—automatically
Equity alignment replaces complex M&A
Milestones to Watch
$0.0004–$0.0005: Technical breakout zone triggered by strategic partnerships
$0.003: Viral press momentum = 3,000% ROI
$0.01: Quarterly catalyst ($400K revenue) = copper-grade breakout
$0.04: Profit traction ($10M) = 40,000% Bitcoin-level surge
$0.10–$1.00: Full market momentum ($25M profit) = 100,000% return
Smart Tech + Lean Economics
AI app adapts therapy to user patterns
Tailors relief based on lifestyle, weather, and activity data
$35/month per device = Netflix-level affordability, no FDA bottlenecks
High-margin, low-overhead infrastructure allows scale across human & veterinary markets
Veterinary Opportunity
RecoveryRx Vet® outperforms Assisi Loop ($329) with 20x battery life
Premium e-commerce bundling opens a goldmine in pet wellness
Retail-ready, influencer-friendly, and margin-rich
Tax-Efficient Profitability
$40M tax-loss carryforward = early profits are tax-free
Viral press at $0.003 can trigger GameStop-style surge
Share buybacks post loan payoff drive valuation acceleration ($1/share?)
Final Word: Execute. Accumulate. Prosper.
Viant builds. VLMS bills. BIEL heals. Shareholders win.
This is Smart Pain Relief Alliance—where scalable pain therapy meets frictionless equity participation. No contracts. No barriers. Just the pure upside of execution-fueled prosperity.
1
